The global endocrinology drugs market reached USD 3.5 billion in 2017 and is expected to reach USD 6.2 billion by 2028, growing at a CAGR of 7.9% during the forecast period from 2021-2028. Diabetes drugs accounted for the largest share of this market in 2017 with about 30%, followed by testosterone replacement drugs (19%), human growth hormone (HGH) drugs (14%), thyroid hormone disorder drugs (11%). North America dominated this market accounting for more than 40% share of the total revenues in 2017 as compared to Europe and the Asia Pacific which accounted mainly due to their high healthcare spending rates and large population size respectively.
Endocrinology drugs are medicines that affect the endocrine system and help manage certain medical conditions. Examples of these types of drugs include thyroid hormone disorder drugs, diabetes medications, human growth hormones (HGH), testosterone replacement therapy medication, etc. These treatments can be used in hospitals or ambulatory care centers to treat a number of health problems including hormonal imbalances caused by diseases like hypothyroidism and adrenal insufficiency.
On the basis of type, endocrinology drugs are segmented into diabetes drugs, testosterone replacement therapy medications, human growth hormone (HGH), and thyroid hormone disorder medicines.
Diabetes endocrinology drugs are a type of pharmaceuticals that manage the disorder by controlling blood glucose levels. These diabetes endocrinology drugs have been shown to be more effective than insulin itself in managing Type Two Diabetes, particularly when combined with exercise and diet changes.
Testosterone replacement therapy medications are drugs that replace the male hormone, testosterone. Testosterone is produced by the testicles in males and released into the bloodstream where it travels to cells throughout the body. They are the drugs that can be used to treat testosterone deficiency. Testosterone is a male sex hormone and helps control sexual function, body hair, muscle mass, red cell production in the blood, and sperm production for men. Low levels of this hormone may lead to symptoms such as low libido (sex drive), difficulty achieving an erection adequate for penetrative intercourse, or infertility.
HGH endocrine drugs are medications that act on certain hormones in the body to stimulate growth. The three most common types of HGH endocrine drugs are Growth hormone replacement therapy, human growth hormone deficiency (or GH-D), and pediatric cases with insufficient endogenous production of human growth hormone. There is a growing need for treatment as many individuals develop diseases related to age or other factors which can lead to decreased levels of natural HGH secretion.
Thyroid hormone disorder medicines are medications that help in the management of thyroid disorders. It includes synthetic hormones such as thyroxine and liothyronine, which replace or supplement the deficient levels in patients suffering from low production of these hormones due to thyroid gland diseases; radioactive iodine therapy; antithyroid drugs for prevention and treatment of hyperthyroidism (excess secretion by the thyroid) and hypothyroidism (deficient secretion by the thyroid).
On the basis of application, endocrinology drugs are segmented into hospitals, commercial laboratories, and other settings.
Endocrinology drugs are used in hospitals for the treatment of disorders related to hormones, such as diabetes and thyroid hormone disorder. Hospitals typically use specific endocrinology drug types depending on factors like their type and size. For instance, large hospitals may require more advanced medication than smaller ones because they have a greater capacity to manage patients with complex medical conditions.
Endocrinology drugs are used in commercial laboratories to provide a personalized treatment plan for patients. In this way, endocrinologists can monitor the effects of different medications and determine any side effects or reactions from treatments in order to prescribe an appropriate dosage. Most of the endocrinology drugs are used in hospitals and other settings. However, some of them are also being commonly found in commercial laboratories for research purposes or to prepare medications for future use.
The other setting includes self-medication centers, university hospitals, and clinics, polyclinics, or general practitioners.
On the basis of region, the global endocrinology drugs market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the global endocrinology drugs market due to the higher availability of advanced healthcare facilities in this region. The U.S., with its large population size, is a major contributor to the North American segmentation of the endocrinology drugs market. In addition, Canada has also emerged as an important country contributing towards increment in demand for specialty hospitals which are mainly focused on diabetes care management
Asia-Pacific is projected to grow at the fastest CAGR during the forecast period owing to increasing awareness about obesity among people coupled with improving economic conditions that have led to increased healthcare expenditure across Asia Region.
The global endocrinology drugs market has witnessed significant growth in the past few years. The surging populations of obese and diabetic patients are likely to increase demand for diabetes-related drug treatments while raising awareness about hormonal imbalance disorders also supports the growth of this market. Rising awareness about gene therapy as an effective treatment option is expected to create opportunities for various pharmaceutical companies between 2018 and 2028.
Up Market Research published a new report titled “Endocrinology Drugs Market research report which is segmented by Types (Diabetes Drugs, Testosterone Replacement Drugs, Human Growth Hormone Drugs, Thyroid Hormone Disorder Drugs), By Applications (Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting), By Players/Companies AbbVie, AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi”. As per the study, the market is expected to grow at a CAGR of XX% in the forecast period.
|Report Attributes||Report Details|
|Report Title||Endocrinology Drugs Market Research Report|
|By Type||Diabetes Drugs, Testosterone Replacement Drugs, Human Growth Hormone Drugs, Thyroid Hormone Disorder Drugs|
|By Application||Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting|
|By Companies||AbbVie, AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||208|
|Number of Tables & Figures||146|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Diabetes Drugs, Testosterone Replacement Drugs, Human Growth Hormone Drugs, Thyroid Hormone Disorder Drugs and By Application Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting.
Some of the companies that are profiled in this report are:
Endocrinology Drugs Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Endocrinology Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Endocrinology Drugs Market Report:
Some other reports from this category!